1. Home
  2. BLTE vs AX Comparison

BLTE vs AX Comparison

Compare BLTE & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$173.05

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$92.92

Market Cap

5.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
AX
Founded
2018
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.4B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
BLTE
AX
Price
$173.05
$92.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$198.00
$103.14
AVG Volume (30 Days)
198.1K
235.6K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.13
EPS
N/A
8.48
Revenue
N/A
$81,254,000.00
Revenue This Year
N/A
$24.76
Revenue Next Year
$492.11
$10.86
P/E Ratio
N/A
$11.00
Revenue Growth
N/A
23.51
52 Week Low
$65.00
$74.89
52 Week High
$200.00
$105.74

Technical Indicators

Market Signals
Indicator
BLTE
AX
Relative Strength Index (RSI) 54.90 38.65
Support Level $167.80 $91.90
Resistance Level $182.61 $100.51
Average True Range (ATR) 7.90 2.00
MACD 2.18 -0.44
Stochastic Oscillator 48.43 12.70

Price Performance

Historical Comparison
BLTE
AX

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About AX Axos Financial Inc.

Axos Financial Inc is a technology-driven, diversified financial services company. Its client-centric, technology-enabled services model provides secure and scalable banking, clearing and custody, and investment advisory solutions to retail and business customers. The Bank provides consumer and commercial banking products and services through its digital online and mobile banking platforms, low-cost distribution channels and affinity partners. It offers deposit and lending products to customers nationwide including consumer and business checking, savings, etc. Its segments are Banking Business Segment and the Securities Business Segment. Majority of income comes from Banking Business Segment- It distribute its loan products through its retail, correspondent and wholesale channels.

Share on Social Networks: